It’s always exciting when your lab has a new paper and my team just published a study knocking out the H3f3a gene in mice, which codes for histone H3.3 protein. We found that loss of this gene leads to lethality at a late stage of embryonic development. There were also indications of more specific phenotypes […]
Weekly reads: H3.3 on the brain, Texas bill, HSCs Read More »
I’ve tried to find some time to do some stem cell and other regenerative medicine reading too, but it’s been a busy week of teaching for me as a professor in our new academic year for the UC Davis School of Medicine. I help to teach the Histology part of the first-year curriculum. It’s an
Regenerative medicine reads: retraction, FDA warning, CAR-T, ARM CEO Read More »
The last six months I’ve been spending even more time than usual writing NIH grants (and a few others). The last two weeks have been especially busy on this front as I am getting an R01 renewal out the door. My paper reading lately has been mostly related to the grant writing I’m doing. Still,
Weekly reads: NIH grants, side effect of darker hair, FDA warning, CRISPR Read More »
It seems like the field of cell biology has mixed feelings about fibroblasts so I’m going to start off there with the recommended reads. But first, check out our stem cell YouTube channel as we are steadily heading toward 500 subscribers and 30,000 views. Please subscribe. I’ve pasted one of our top videos below, which
Weekly reads: fibroblasts, cancer stem cells, Parkinson’s Read More »
When we hear the word senile we might think stereotypically of an older person who has cognitive impairment, but some argue that senility can apply to cells too as they age and that such cells can be targeted by drugs called senolytics. Unfortunately, the supplements industry has picked up on this idea to sell iffy
Recommended reads: senolytics, cow iPS cells, big CIRM royalty Read More »
Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end
Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »
Joe Rogan first popped up more squarely on my radar screen years ago because of a concerning video that’s out there of him talking with Mel Gibson about stem cells. At the time it was one of the most-watched videos on YouTube on stem cells. I took apart that stem cell video and its claims including
About that Joe Rogan stem cell treatment & clinic promotion Read More »
A clever idea to try to use AI to make cellular machines has produced something being called xenobots. However, the research is getting overblown in some ways. What does this have to do with Zambonis? Read on. What are xenobots? A xenobot is supposed to be a cellular robot made from frog stem cells. The robot part
Xenobots, Zambonis, and cellular hype Read More »
The other day I was talking with some folks about stem cell policy on Zoom, which was great, but one phrase from them jumped out at me and gave me a laugh. “Joe Rogan is the Gwyneth Paltrow for bros.” It also just rings true to me. Some readers of The Niche may remember that
Weekly reads: Joe Rogan, stem cell, diet, clinics, more Read More »
As many of you know I am a cancer survivor myself so studying cancer stem cells has meaning for me on another level. Cancer is also the possible side effect most patients worry about when considering going to an unproven stem cell clinic. I’ve got a new video up on possible stem cell side effects
Weekly reads: cancer stem cells, Bik, & more Read More »